CERO SCHEDULE 13G/A: SEC filing

An institutional holder

Filed with the SEC on Aug 14, 2026 · accession 0001376474-26-000565

CERO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. An institutional holder filed an amended Schedule 13G for Cero Therapeutics Holdings, Inc., indicating a change in beneficial ownership position.

Summary of the filing

An institutional holder filed an amended Schedule 13G for Cero Therapeutics Holdings, Inc., indicating a change in beneficial ownership position. The filing is a routine passive ownership disclosure with no stated intent to influence control.

For details, click here →

Key details

IssuerCero Therapeutics Holdings, Inc.

✦ Ask GOAX AI about this filing — what it means for CERO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CERO?

Click here

Frequently asked questions

What did CERO file with the SEC on Aug 14, 2026?

CERO filed a SCHEDULE 13G/A (SEC filing). An institutional holder filed an amended Schedule 13G for Cero Therapeutics Holdings, Inc., indicating a change in beneficial ownership position. The filing is a routine passive ownership disclosure with no stated intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

Other CERO SEC filings

Get alerts when CERO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

CERO overview CERO analysis CERO news Latest SEC filings